JOSHUA WILDING: Open Payments
NPI 1538565270 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 28 payments from 17 companies in 2025. Trend: 2023 $451 · 2024 $551 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $107 |
| ABBVIE INC. | 4 | $102 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| Amgen Inc. | 2 | $43 |
| Stryker Corporation | 1 | $41 |
| Edwards Lifesciences Corporation | 1 | $29 |
| Lilly USA, LLC | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
Products named: Wegovy, TRELEGY ELLIPTA, UBRELVY, QULIPTA, MAKO, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), REPATHA, LEQVIO.
Industry payments across ID — which companies pay providers there.
